Plain-English translation of NCT05473520 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , an antibiotic, can help protect your lungs when taken alongside your regular TB medications. Researchers believe this medication may prevent lung damage and help your lungs heal better during TB treatment. You would take it for 8 weeks while also taking your standard TB drugs, then continue with TB treatment alone for about 2 more years.
TB can cause permanent lung damage and scarring, even after the infection is cleared. This study aims to see if adding this medication early in treatment can prevent that damage and help your lungs recover more fully.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the new medication or a placebo (inactive pill), both taken twice daily for 8 weeks along with your standard TB drugs. During the study, you would have regular visits including lung function tests, imaging scans, heart tests, and blood work at different time points over 22 months total. You would need to commit to all scheduled appointments and follow-up visits.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Malaysia
Singapore